Mumbai, Feb. 6 -- Gland Pharmahas received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Zoledronic Acid Injection, 4 mg/100 mL (0.04 mg/ mL) Single-Dose Bags.

Published by HT Digital Content Services with permission from Capital Market....